Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive pulmonary disease (COPD). Includes Anoro side effects, interactions and indications.

Jun 2, 2023 · The recommended dosage of ANORO ELLIPTA for maintenance treatment of COPD is 62.5 mcg umeclidinium and 25 mcg vilanterol (1 actuation of ANORO ELLIPTA 62.5/25 mcg) once daily by oral inhalation.

Sep 26, 2023 · Do not use Anoro Ellipta with other inhalers that also contain LABAs such as Advair, Breo Ellipta, or inhalers containing salmeterol, formoterol fumarate, arformoterol tartrate, or indacaterol. Combining beta-agonist medications may lead to a fast heart rate (tachycardia), elevated blood pressure, irregular heart rhythm, and possibly death.

Oct 28, 2024 · Anoro Ellipta Side Effects. Generic name: umeclidinium / vilanterol Medically reviewed by Drugs.com. Last updated on Oct 28, 2024.

Dec 18, 2013 · Medicament dispenser Patent 8,161,968 Issued: April 24, 2012 Inventor(s): Augustyn Stephen & Davies Michael Birsha & Harvey Stephen James & Rand Paul Kenneth

Anoro Ellipta Coupons, Copay Cards and Rebates. Anoro Ellipta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples.

Sep 9, 2024 · Trelegy Ellipta and Anoro Ellipta are oral inhalers for the long-term treatment of COPD. They are not used for sudden breathing problems. Do not use both of these medicines; use one or the other as prescribed by your doctor. Trelegy is also approved for maintenance treatment of asthma, but Anoro is not.

Compare Anoro Ellipta head-to-head with other drugs for uses, ratings, cost, side effects and interactions.

Mar 19, 2024 · References. Anoro Ellipta. [package insert]. 6/2023. Research Triangle Park, NC. GlaxoSmithKline. Accessed March 18, 2024.

Mar 25, 2024 · No, Anoro is not a steroid (corticosteroid) medication and does not contain any steroids. Anoro contains two inhaled bronchodilator agents: umeclidinium, a long-acting muscarinic antagonist (LAMA, also known as an anticholinergic agent) and vilanterol, a long-acting beta2-agonist (LABA).